Search

everythinglearnresearchcommunity

for

Search:↓

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Minoxidil was first made for high blood pressure, but it was later found to help hair growth.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The document concludes that more research is needed to fully understand the causes of PCOS.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Early treatment helps stop hair loss in women of color.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Two gene variations, rs6493497 and rs7176005, may be linked to female hair loss in Chinese people.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Women with alopecia may have a higher chance of getting thyroid cancer.